
Targeted Gene Editing
Achieve precise genetic modifications in mice and rats with fast, cost-effective, and high-efficiency gene editing – powered by AI-optimized guide design and proprietary delivery techniques.

Wide Compatibility
Supports diverse model types across multiple strains and species.

High Editing Precision
AI-optimized guide molecules and enhanced HDR minimize off-target risks and improve editing fidelity.

Fast Turnaround
Accelerate your research with rapid model generation and efficient service delivery.
Technology
Applications
FAQs
How Targeted Gene Editing Works
Our Targeted Gene Editing platform introduces precise double-strand
breaks (DSBs) at specific genomic locations using AI-optimized guide
molecules. These breaks are repaired via homology-directed repair (HDR),
enabling the accurate insertion, deletion, or replacement of genetic
sequences.
Unlike traditional methods that primarily rely on non-homologous end
joining (NHEJ)—which often leads to small insertions or deletions
(indels)—our proprietary fertilization technique enhances HDR
efficiency, making it ideal for complex model generation such as
large-fragment knockin and conditional knockout.
Technology Workflow & Key Advantages
| Feature | Conventional Gene Editing | Cyagen’s Targeted Gene Editing |
|---|---|---|
| Editing Stage | Zygote or ES cell (varies) | Direct embryo-stage editing |
| Targeting Strategy | Random DSB repair (often NHEJ) | HDR-optimized with proprietary fertilization |
| Precision | May result in unpredictable indels | High-precision insertion/deletion/mutation |
| Model Complexity | Limited for large edits | Supports up to 15 kb knockin / 400 kb knockout |
| Guide Molecule Design | Manual or vendor tools | AI-powered (via AlphaKnockout) |
| Efficiency | Variable | Significantly enhanced via HDR boosting |
| Applicable Species | Limited strains | Mouse (C57BL/6, FVB), Rat (SD, Wistar, others) |
Looking for higher success rates and complex model capabilities?
Explore our TurboKnockout® platform →
Citation Database
Molecular Therapy: Methods & Clinical Development, March, 2025
Intracranial AAV administration dose-dependently recruits B cells to inhibit the AAV redosing
【Other】
Gut, February, 2025
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
【Other】
Cell Death & Disease, February, 2025
Mcm5 mutation leads to silencing of Stat1-bcl2 which accelerating apoptosis of immature T lymphocytes with DNA damage
【Other】
Molecular Therapy, February, 2025
Single-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer
【Other】
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.






